Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: A meta-analysis

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1509-1516

  Srivastava, Kshitij ^a   Srivastava, Anvesha ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; BIRC5; Meta analysis; Polymorphism; Survivin

Indexed keywords

SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; ENZYME ACTIVITY; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; PROMOTER REGION; PROTEIN FUNCTION; RISK ASSESSMENT; STATISTICAL ANALYSIS; STOMACH CANCER; ASIAN; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84859076418     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0889-9     Document Type: Article

References (43)

1. Altieri DC, Marchisio PC (1999) Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79(11):1327-1333
2. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3(1):46-54. doi:10.1038/nrc968 (Pubitemid 37328886)
3. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC (1998) Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152(1):43-49 (Pubitemid 28028045)
4. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8):917-921 (Pubitemid 27353455)
5. Fukuda S, Pelus LM (2006) Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5(5):1087-1098. doi:10.1158/1535-7163. MCT-05-0375 (Pubitemid 43881300)
6. Ambrosini G, Adida C, Sirugo G, Altieri DC (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273(18):11177-11182 (Pubitemid 28204967)
7. Krieg A, Mahotka C, Krieg T, Grabsch H, Muller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD (2002) Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer 86(5):737-743. doi:10.1038/sj.bjc.6600153 (Pubitemid 34250816)
8. Li F (2003) Survivin study: what is the next wave? J Cell Physiol 197(1):8-29. doi:10.1002/jcp.10327 (Pubitemid 37486223)
9. Ikeguchi M, Ueta T, Yamane Y, Hirooka Y, Kaibara N (2002) Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin Cancer Res 8(10):3131-3136 (Pubitemid 35155022)
10. Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF (2007) Survivin expression in patients with non-muscle-invasive uro-thelial cell carcinoma of the bladder. Urology 70(3):482-486. doi:10.1016/j.urology.2007.05.009 (Pubitemid 47464512)
11. Lo Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De Rosa G, Kudo Y, Takata T, Altieri DC (2003) Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82(11):923-928 (Pubitemid 41756876)
12. Shariat SF, Lotan Y, Saboorian H, Khoddami SM, Roehrborn CG, Slawin KM, Ashfaq R (2004) Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer 100(4):751-757. doi:10.1002/cncr.20039 (Pubitemid 38176853)
13. Tu CH, Liu WP, Dong M, Cai LP, Mo YQ, Yang DZ (2011) Protection of CHO cells by transfer of survivin driven by ovarian-specific promoter OSP-2. Mol Biol Rep 38(4):2323-2328. doi: 10.1007/s11033-010-0365-y
14. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M (2002) Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. Int J Oncol 21(2):315-320
15. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58(22):5071-5074 (Pubitemid 28521163)
16. Raj D, Liu T, Samadashwily G, Li F, Grossman D (2008) Sur-vivin repression by p53, Rb and E2F2 in normal human mela-nocytes. Carcinogenesis 29(1):194-201. doi:10.1093/carcin/bgm 219 (Pubitemid 351201759)
17. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, Cook BP, Dufault MR, Ferguson AT, Gao Y, He TC, Hermeking H, Hiraldo SK, Hwang PM, Lopez MA, Luderer HF, Mathews B, Petroziello JM, Polyak K, Zawel L, Kinzler KW et al (1999) Analysis of human transcriptomes. Nat Genet 23(4):387-388. doi:10.1038/70487
18. Altieri DC (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8(1):61-70. doi: 10.1038/nrc2293
19. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, Fujii Y (2001) Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95(2): 92-95. doi:10.1002/1097-0215(20010320)95:2\92:AID-IJC1016[ 3.0.CO;2-9 (Pubitemid 32187079)
20. Sarela AI, Scott N, Ramsdale J, Markham AF, Guillou PJ (2001) Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 8(4):305-310 (Pubitemid 32422855)
21. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ (2000) Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46(5):645-650 (Pubitemid 30305781)
22. Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita K, Kurisu K (2003) Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97(4):1077-1083. doi:10.1002/cncr.11122 (Pubitemid 36173161)
23. Vischioni B, van der Valk P, Span SW, Kruyt FA, Rodriguez JA, Giaccone G (2004) Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann Oncol 15(11):1654-1660. doi:10.1093/annonc/mdh436 (Pubitemid 39562606)
24. Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S (2003) Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 200(5):620-626. doi:10.1002/path.1388 (Pubitemid 36987311)
25. Mellai M, Caldera V, Patrucco A, Annovazzi L, Schiffer D (2008) Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res 28(1A):109-118 (Pubitemid 351362888)
26. Dai J, Jin G, Dong J, Chen Y, Xu L, Hu Z, Shen H (2010) Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival. J Thorac Oncol 5(11):1748-1754. doi: 10.1097/JTO.0b013e3181f18cb9
27. Xu Y, Fang F, Ludewig G, Jones G, Jones D (2004) A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 23(9):527-537. doi:10.1089/ 1044549041939278 (Pubitemid 39244331)
28. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19(4):251-253
29. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24(9):1291-1306. doi:10.1002/sim.2010 (Pubitemid 40585169)
30. Wang YH, Chiou HY, Lin CT, Hsieh HY, Wu CC, Hsu CD, Shen CH (2009) Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology 73(3):670-674. doi:S0090-4295(08)01675-0[pii]10.1016/j.urology.2008.09.048
31. Pennati M, Folini M, Zaffaroni N (2008) Targeting survivin in cancer therapy. Expert Opin Ther Targets 12(4):463-476. doi: 10.1517/14728222.12.4.463 (Pubitemid 351551639)
32. Ma F, Zhang H, Zhai Y, Huang W, Zhao C, Ou S, Zhou H, Yuan W, Wang Z, Wang H, Yue W, Yu L, Li P, Xia X, Cai M, Zhang Y, Cui Y, He F, Ma Y, Zhou G (2011) Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopha-ryngeal carcinoma among Chinese. PLoS One 6(2):e16748. doi: 10.1371/journal.pone.0016748
33. Bayram S, Akkiz H, Bekar A, Akgollu E (2011) The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population. Cancer Epidemiol. doi:10.1016/j.canep.2011.01.004
34. Borges BD, Burbano RR, Harada ML (2010) Survivin -31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med. doi:10.1007/s10238-010-0122-5
35. Kawata N, Tsuchiya N, Horikawa Y, Inoue T, Tsuruta H, Maita S, Sato S, Mitobe Y, Narita S, Habuchi T (2010) Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility. Int J Cancer. doi:10.1002/ijc.25850
36. Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B (2010) Role of survivin gene promoter polymorphism (-31G[C) in susceptibility and survival of esophageal cancer in Northern India. Ann Surg Oncol. doi:10.1245/s10434-010- 1371-y
37. Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, Taka S, Gazouli M (2010) Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas 39(7):976-980. doi:10.1097/MPA.0b013e3181d705d4
38. Bae GU, Yang YJ, Jiang G, Hong M, Lee HJ, Tessier-Lavigne M, Kang JS, Krauss RS (2009) Neogenin regulates skeletal myofiber size and focal adhesion kinase and extracellular signal-regulated kinase activities in vivo and in vitro. Mol Biol Cell 20(23):4920-4931. doi:10.1091/mbc.E09-06-0491
39. Gazouli M, Tzanakis N, Rallis G, Theodoropoulos G, Papacon-stantinou I, Kostakis A, Anagnou NP, Nikiteas N (2009) Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis 24(2):145-150. doi:10.1007/s00384-008-0601-2
40. Yang L, Zhu H, Zhou B, Gu H, Yan H, Tang N, Dong H, Sun Q, Cong R, Chen G, Wang B (2009) The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci 54(5):1021-1028. doi:10.1007/s10620-008-0441-5
41. Jang JS, Kim KM, Kang KH, Choi JE, Lee WK, Kim CH, Kang YM, Kam S, Kim IS, Jun JE, Jung TH, Park JY (2008) Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60(1):31-39. doi:10.1016/j.lungcan.2007.09.008 (Pubitemid 351434465)
42. Borbely AA, Murvai M, Szarka K, Konya J, Gergely L, Hernadi Z, Veress G (2007) Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 60(3):303-306. doi:10.1136/jcp. 2006.037804 (Pubitemid 46447748)
43. Cheng ZJ, Hu LH, Huang SJ (2008) Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma. Ai Zheng 27(3):258-263